Inactivation of Myocardin and p16 during Malignant Transformation Contributes to a Differentiation Defect

Delineation of prognostic biomarkers in prostate cancer

Saravana M. Dhanasekaran, Terrence R. Barrette, Debashis Ghosh et al. · Nature · 2001 · 1.7K citations · Full text

Medicine, Oncology, Urology +14

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

Jacques Lapointe, Chunde Li, Matt van de Rijn et al. · Proceedings of the National Academy of Sciences · 2004 · 1.3K citations · Full text

Medicine, Molecular Biology, Oncology +17

Correlation of Terminal Cell Cycle Arrest of Skeletal Muscle with Induction of p21 by MyoD

Orna Halevy, Bennett G. Novitch, Douglas B. Spicer et al. · Science · 1995 · 1.2K citations

Life Sciences, Cell Biology, Molecular Biology +17

Activation of Cardiac Gene Expression by Myocardin, a Transcriptional Cofactor for Serum Response Factor

Da‐Zhi Wang, Priscilla S. Chang, Zhigao Wang et al. · Cell · 2001 · 895 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

Norman E. Sharpless, Nabeel Bardeesy, Kee-Ho Lee et al. · Nature · 2001 · 850 citations

Medicine, Molecular Genetics, Oncology +12